When was Alphalyse founded?

Alphalyse was founded in 2002 and raised its 1st funding round 12 years after it was founded.

Where is Alphalyse located?

Alphalyse is headquartered in Odense, Denmark.

Who is the current CEO of Alphalyse?

Thomas Kofoed of Alphalyse. They have also founded 1 company.

Which legal entities is Alphalyse associated with?

Alphalyse is associated with ALPHALYSE A/S.

How many employees does Alphalyse have?

As of Jun 30, 2026, the latest employee count at Alphalyse is 47.

Is Alphalyse a funded company?

Alphalyse is a funded company, having raised an undisclosed amount across 4 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on 2014.

When was the latest funding round of Alphalyse?

Alphalyse's latest funding was a $***** Grant (prize money) round on Oct 01, 2017, with participation from 1 investor.

Where does Alphalyse rank among its competitors?

Alphalyse ranks 13th amongst 175 active competitors, of which 31 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Arzeda, which secured $4.51M in Aug, 2025.

Who are the top competitors of Alphalyse?

Alphalyse's top competitors include Nautilus Biotechnology, Somalogic and Biognosys. Among them, Arzeda secured the most recent funding round in August, 2025.

Alphalyse - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Provider of protein analysis services. The company accelerates drug development through impurity analysis and analytical protein characterization services based on mass spectrometry. Also, it offers services like the analytical characterization of biopharmaceuticals, mass spectrometric peptide mapping, host cell protein analysis, and quantification of specific proteins in complex samples.

Website: alphalyse.com
Social
Email ID: *****@alphalyse.com
Phone Number: +45 **********

Key Metrics

Founded Year

2002

Location

Odense, Denmark

Stage

Acquired

Latest Funding Round

Grant (prize money), Oct 01, 2017, $*****

Investors

Europa

Ranked

13^th among 175 active competitors

Employee Count

47 as on Jun 30, 2026

Similar Companies

Nautilus Biotechnology & 235 more

Exit Details

Acquired by Fidelio Capital (Jul 02, 2025)

View Alphalyse's full profile

Alphalyse is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ALPHALYSE A/S CIN: 26753864 , Denmark, Active		-	23 (As on Dec 31, 2022)

Alphalyse got acquired by Fidelio Capital on Jul 02, 2025.

Click here to take a look at Alphalyse's acquisition in detail

Alphalyse has raised funding over 4 rounds. Its first funding round was on 2014. Its latest funding round was a Grant (prize money) round on Oct 01, 2017 for $*****. 1 investor participated in its latest round. Alphalyse has 1 institutional investor.

Here is the list of recent funding rounds of Alphalyse:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 01, 2017	3613189	Grant (prize money)	1592223	2321509	5648402	1445729
Jan 10, 2017	8968480	Grant (prize money)	2070048	1205542	5430241	Europa
Nov 03, 2016	3847310	Grant (prize money)	4759782	1835879	6210042	6008760

Access funding benchmarks and valuations. Sign up today!

View details of Alphalyse's funding rounds and investors

The founders of Alphalyse are Thomas Kofoed and Ejvind Mortz.

Here are the details of Alphalyse's key team members:

Thomas Kofoed: CEO and founder of Alphalyse.
Ejvind Mortz: Co-Founder & COO of Alphalyse.

View details of Alphalyse's Founder profiles and Board Members

Alphalyse's employee count trend

Alphalyse has 47 employees as of Jun 26. Here is Alphalyse's employee count trend over the years:

Uncover Alphalyse's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Alphalyse include Nautilus Biotechnology, Somalogic and Biognosys. Here is the list of Top 10 competitors of Alphalyse, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nautilus Biotechnology 2016, Seattle (United States), Public	Developer of proteomics platform for drug development	$453M	Vulcan, Bain Capital Life Sciences & 8 others	65/100
2nd	Somalogic 1999, Boulder (United States), Acquired	Developer of protein-based assays for life science research	$664M	ProQuest Investments, ICarbonX & 27 others	64/100
3rd	Biognosys 2008, Schlieren (Switzerland), Acquired	Provider of proteomics service	$9.13M	Zurcher Kantonalbank, Syngenta Group & 6 others	63/100
4th	Arzeda 2008, Seattle (United States), Series B	Developer of enzyme design technology to bridge the gap by creating synthetic enzymes	$95.2M	OS Fund, Conti Ventures & 22 others	58/100
5th	Amunix 2006, Mountain View (United States), Acquired	Developer of peptide-based therapeutics	$201M	Viking Global Investors, Omega Funds & 18 others	57/100
6th	A-Alpha Bio 2017, Seattle (United States), Series A	Developer of cell-based tool for the measurements of protein interactions	$45.2M	Xontogeny, OS Fund & 15 others	56/100
7th	Dynamic Biosensors 2011, Planegg (Germany), Acquired	Provides solutions for label-free molecular interaction and biophysical analysis	$5.83M	Rurode, EXTOREL & 19 others	56/100
8th	Mursla 2017, London (United Kingdom), Seed	Provider of diagnostic device for cancer detection	$547K	Future Fund, TA Ventures & 26 others	55/100
9th	ProteinSimple 2004, San Jose (United States), Acquired	Provider tools to help researchers with protein analysis	$94.3M	Lansing Brown Investments, Royal Bank of Canada ... & 10 others	54/100
10th	Cevec Pharmaceuticals 2001, Cologne (Germany), Acquired	Provider of glyco-optimised human cell lines and gene therapy vectors using proprietary cell expression system	$28.4M	Peppermint VenturePartners, NRW.Bank & 28 others	52/100
13th	Alphalyse 2002, Odense (Denmark), Acquired	Provider of protein analysis services	-	Europa	33/100